Treating pulmonary arterial hypertension: current treatments and future prospects
Population
Patients with pulmonary arterial hypertension (PAH)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports informed PAH management decisions; leaves open validation of emerging targets in trials.
Structured PICO
P
Population
Patients with pulmonary arterial hypertension (PAH)
I
Intervention
Current treatments (endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostacyclin derivatives) and novel therapeutic targets
This review summarizes the current treatment paradigm for pulmonary arterial hypertension and highlights numerous emerging therapeutic targets under investigation.
Cite This Study
Raja et al. (2011) studied this question.